GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Insider Ownership

Concord Biotech (BOM:543960) Insider Ownership : 0.00 % (As of May. 29, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Concord Biotech's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Concord Biotech's Institutional Ownership is 8.53%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Concord Biotech's Float Percentage Of Total Shares Outstanding is 0.00%.


Concord Biotech Insider Ownership Historical Data

The historical data trend for Concord Biotech's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Insider Ownership Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Insider Ownership
- - - - -

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Insider Ownership Get a 7-Day Free Trial - - - - -

Concord Biotech Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Concord Biotech (BOM:543960) Business Description

Traded in Other Exchanges
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines